Daclizumab (Systemic)

Brand Names : Zenapax, dacliximab

Category

• Immunosuppressant
• monoclonal antibody

Description

Daclizumab (da-KLIZ-yoo-mab) belongs to a group of medicines known as immunosuppressive agents. It is used to lower the body's natural immunity in patients who receive kidney transplants.

When a patient receives a kidney transplant, the body's white blood cells will try to get rid of (reject) the transplanted kidney. Daclizumab works by preventing the white blood cells from getting rid of the transplanted kidney. The effect of daclizumab on the white blood cells may also reduce the body's ability to fight infections.

Daclizumab is to be administered only by or under the immediate supervision of your doctor. It is available in the following dosage form:

Parenteral
• Injection (U.S.)

Brand Names

Some commonly used brand names are:

In the U.S. -

• Zenapax

Another commonly used name is dacliximab .